EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lung Ultrasound in Predicting Outcomes in Patients with COVID-19 Treated with Extracorporeal Membrane Oxygenation

Valentin Sebastian Schäfer iD, Florian Recker iD, Edgar Kretschmer, Christian Putensen, Stefan Felix Ehrentraut iD, Christian Staerk, Tobias Fleckenstein, Andreas Mayr iD, Armin Seibel iD, Jens-Christian Schewe iD, Simon Michael Petzinna iD

Viruses · 2023

DOI: 10.3390/v15091796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Valentin Sebastian Schäfer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, 53113 Bonn, Germany. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary involvement due to SARS-CoV-2 infection can lead to acute respiratory distress syndrome in patients with COVID-19. Consequently, pulmonary imaging is crucial for management of COVID-19. This study aimed to evaluate the prognostic value of lung ultrasound (LUS) with a handheld ultrasound device (HHUD) in patients with COVID-19 treated with extracorporeal membrane oxygenation (ECMO). Therefore, patients underwent LUS with a HHUD every two days until they were either discharged from the intensive care unit or died. The study was conducted at the University Hospital of Bonn’s anesthesiological intensive care ward from December 2020 to August 2021. A total of 33 patients (median [IQR]: 56.0 [53–60.5] years) were included. A high LUS score was associated with a decreased P/F ratio (repeated measures correlation [rmcorr]: −0.26; 95% CI: −0.34, −0.15; p < 0.001), increased extravascular lung water, defined as fluid accumulation in the pulmonary interstitium and alveoli (rmcorr: 0.11; 95% CI: 0.01, 0.20; p = 0.030), deteriorated electrolyte status (base excess: rmcorr: 0.14; 95% CI: 0.05, 0.24; p = 0.004; pH: rmcorr: 0.12; 95% CI: 0.03, 0.21; p = 0.001), and decreased pulmonary compliance (rmcorr: −0.10; 95% CI: −0.20, −0.01; p = 0.034). The maximum LUS score was lower in survivors (median difference [md]: −0.35; 95% CI: −0.55, −0.06; p = 0.006). A cutoff value for non-survival was calculated at a LUS score of 2.63. At the time of maximum LUS score, P/F ratio (md: 1.97; 95% CI: 1.12, 2.76; p < 0.001) and pulmonary compliance (md: 18.67; 95% CI: 3.33, 37.15; p = 0.018) were higher in surviving patients. In conclusion, LUS with a HHUD enables continuous evaluation of cardiopulmonary function in COVID-19 patients receiving ECMO support therapy and provides prognostic value in determining the patients’ likelihood of survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19LungHumansMaleFemaleMiddle AgedUltrasonographyPrognosisSARS-CoV-2Treatment OutcomeAged

Stichwörter der Autor:innen

acute respiratory distress syndromecoronavirus disease 2019 (COVID-19)extracorporeal membrane oxygenationhandheld ultrasound devicelung ultrasoundsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ultrasound

Autor:innen und Institutionen

  • Department of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, 53113 Bonn, Germany.
  • Department of Obstetrics and Gynecology, University Hospital of Bonn, 53113 Bonn, Germany.
  • Department of Anaesthesiology and Intensive Care Medicine, University Hospital of Bonn, 53113 Bonn, Germany.
  • Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, 53113 Bonn, Germany.
  • Department of Intensive Care Medicine, DRK Hospital Kirchen, 57548 Kirchen, Germany.
  • Department of Anaesthesiology Intensive Care Medicine and Pain Therapy, University Medical Centre Rostock, 18057 Rostock, Germany.

ORCID-Profile: Valentin Sebastian Schäfer, Florian Recker, Stefan Felix Ehrentraut, Andreas Mayr, Armin Seibel, Jens-Christian Schewe, Simon Michael Petzinna

Zitieren

APA

Schäfer, V. S., Recker, F., Kretschmer, E., Putensen, C., Ehrentraut, S. F., Staerk, C., Fleckenstein, T., Mayr, A., Seibel, A., Schewe, J. C., & Petzinna, S. M. (2023). Lung Ultrasound in Predicting Outcomes in Patients with COVID-19 Treated with Extracorporeal Membrane Oxygenation. Viruses. https://doi.org/10.3390/v15091796

Vancouver

Schäfer VS, Recker F, Kretschmer E, Putensen C, Ehrentraut SF, Staerk C, et al. Lung Ultrasound in Predicting Outcomes in Patients with COVID-19 Treated with Extracorporeal Membrane Oxygenation. Viruses. 2023. doi:10.3390/v15091796

BibTeX
@article{Schfer2023,
  author = {Schäfer, Valentin Sebastian and Recker, Florian and Kretschmer, Edgar and Putensen, Christian and Ehrentraut, Stefan Felix and Staerk, Christian and Fleckenstein, Tobias and Mayr, Andreas and Seibel, Armin and Schewe, Jens-Christian and Petzinna, Simon Michael},
  title = {Lung Ultrasound in Predicting Outcomes in Patients with COVID-19 Treated with Extracorporeal Membrane Oxygenation},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15091796}
}
Kostenlos starten →